Bacterial resistance and failure of clinical cure could be produced by oxidative stress in patients with diabetes or cardiovascular diseases during fluoroquinolone therapy.
| Image |  |
|---|---|
| Description | scientific article published on 5 April 2017 |
| Author/s |
author: Mario Isiordia-Espinoza |
| Publication date | April 5, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |